Bioventus Inc.
US ˙ NasdaqGS ˙ US09075A1088

SecurityBVS / Bioventus Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership873,138 shares
Latest Disclosed Value $ 7,970,934
Dimensional Fund Advisors Lp reports 14.10% increase in ownership of BVS / Bioventus Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 873,138 shares of Bioventus Inc. (US:BVS) valued at $7,971,750 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 765,208 shares of Bioventus Inc.. This represents a change in shares of 14.10% during the quarter. The current value of the position is $7,465,330 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F BIOVENTUS COM CL A 09075A108 873,138 107,930 14.10 7,971 40.00 0.0004
2026-02-12 2025-12-31 13F BIOVENTUS COM CL A 09075A108 765,208 21,777 2.93 5,693 14.48 0.0012
2025-11-12 2025-09-30 13F BIOVENTUS COM CL A 09075A108 743,431 71,624 10.66 4,973 11.83 0.0011
2025-08-12 2025-06-30 13F BIOVENTUS COM CL A 09075A108 671,807 150,070 28.76 4,448 -6.83 0.0010
2025-05-13 2025-03-31 13F BIOVENTUS COM CL A 09075A108 521,737 94,315 22.07 4,774 6.35 0.0012
2025-02-13 2024-12-31 13F BIOVENTUS COM CL A 09075A108 427,422 152,311 55.36 4,488 36.58 0.0011
2024-11-07 2024-09-30 13F BIOVENTUS COM CL A 09075A108 275,111 157,615 134.14 3,287 386.81 0.0008
2024-08-09 2024-06-30 13F BIOVENTUS COM CL A 09075A108 117,496 58,954 100.70 676 122.04 0.0002
2024-05-10 2024-03-31 13F BIOVENTUS COM CL A 09075A108 58,542 27,686 89.73 304 87.65 0.0001
2024-02-07 2023-12-31 13F BIOVENTUS COM CL A 09075A108 30,856 10,978 55.23 163 149.23 0.0000
2023-11-09 2023-09-30 13F BIOVENTUS COM CL A 09075A108 19,878 20 0.10 66 14.04 0.0000
2023-08-09 2023-06-30 13F BIOVENTUS COM CL A 09075A108 19,858 -459 -2.26 57 171.43 0.0000
2023-05-12 2023-03-31 13F BIOVENTUS COM CL A 09075A108 20,317 -11,546 -36.24 22 0.0000
2023-02-09 2022-12-31 13F BIOVENTUS COM CL A 09075A108 31,863 -6,286 -16.48 0 -100.00 0.0000
2022-11-10 2022-09-30 13F BIOVENTUS COM CL A 09075A108 38,149 -1,260 -3.20 267 -0.74 0.0001
2022-08-12 2022-06-30 13F BIOVENTUS COM CL A 09075A108 39,409 39,409 269 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.